Enforcement Actions Drop 60%: Pharmaceutical Industry Regulatory Capture of FDA
Internal agency data reveals a dramatic decline in FDA enforcement actions against pharmaceutical companies. Annual warning letters dropped from over 130 in the late 1990s to just three in 2023, indicating a significant reduction in regulatory oversight. Investigations by ProPublica and HHS show …
Regulatory Enforcement Division
Industry Trade Groups
Congressional Oversight
FDA Leadership
Pharmaceutical Manufacturers Association
enforcement-decline
regulatory-capture
industry-influence
oversight-failure
pharmaceutical-industry
+1 more
Read more →